A Medical Clinical Affairs White Paper | June 2018
Authors: Gopa B. Green, MD and Graham Abra, MD
Impressive advances have been made in the treatment of Hepatitis C since 2011 which have now been extended to patients on dialysis. In the attached White Paper we review the diagnosis of Hepatitis C including screening recommendations from the CDC for patients with ESRD, treatment with direct-acting antivirals with attention to drugs that have been studied in patients with advanced renal disease, and the importance of infection control practices in the dialysis center to prevent transmission.
We look forward to seeing improved outcomes for our patients with Hepatitis C and welcome any insights you have from your own practice.